Call Options

29 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $4.78 Million - $6.23 Million
120,400 Added 128.91%
213,800 $11.1 Million
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $26.1 Million - $34.3 Million
-647,900 Reduced 87.4%
93,400 $3.88 Million
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $30 Million - $34 Million
-625,600 Reduced 45.77%
741,300 $40.2 Million
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $18.2 Million - $21.8 Million
376,200 Added 37.97%
1,366,900 $70.1 Million
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $39 Million - $43.6 Million
673,500 Added 212.33%
990,700 $57.5 Million
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $62 Million - $68.8 Million
-973,100 Reduced 75.42%
317,200 $20.3 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $203 Million - $231 Million
-3,092,800 Reduced 70.56%
1,290,300 $89.4 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $149 Million - $176 Million
2,172,600 Added 98.29%
4,383,100 $315 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $54,184 - $32 Million
-416,800 Reduced 15.86%
2,210,500 $157 Million
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $87.7 Million - $96.6 Million
1,207,900 Added 85.1%
2,627,300 $202 Million
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $34.7 Million - $41.6 Million
564,200 Added 65.97%
1,419,400 $104 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $34.3 Million - $40 Million
639,700 Added 296.84%
855,200 $53.3 Million
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $34.4 Million - $40.3 Million
-581,900 Reduced 72.97%
215,500 $12.8 Million
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $4.49 Million - $4.89 Million
-72,500 Reduced 8.33%
797,400 $53.3 Million
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $20.4 Million - $23 Million
-344,600 Reduced 28.37%
869,900 $54.9 Million
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $28.6 Million - $32.4 Million
-494,700 Reduced 28.94%
1,214,500 $75.3 Million
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $11.2 Million - $12.4 Million
195,100 Added 12.89%
1,709,200 $103 Million
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $9.18 Million - $10.7 Million
-167,400 Reduced 9.96%
1,514,100 $89 Million
Q1 2020

May 15, 2020

BUY
$46.4 - $67.43 $20.3 Million - $29.6 Million
438,300 Added 35.26%
1,681,500 $93.7 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $1.53 Million - $2 Million
31,100 Added 2.57%
1,243,200 $79.8 Million
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $35.4 Million - $42 Million
828,100 Added 215.65%
1,212,100 $61.5 Million
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $42.7 Million - $47.2 Million
-956,700 Reduced 71.36%
384,000 $17.4 Million
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $46.9 Million - $55.9 Million
1,038,500 Added 343.65%
1,340,700 $64 Million
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $10.2 Million - $13.3 Million
210,200 Added 228.48%
302,200 $15.7 Million
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $3.75 Million - $4.23 Million
-68,000 Reduced 42.5%
92,000 $5.71 Million
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $33.6 Million - $41.9 Million
-664,700 Reduced 80.6%
160,000 $8.86 Million
Q1 2018

May 15, 2018

BUY
$59.92 - $68.98 $21 Million - $24.1 Million
349,700 Added 73.62%
824,700 $52.2 Million
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $19.5 Million - $21.2 Million
325,000 Added 216.67%
475,000 $29.1 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $8.28 Million - $9.56 Million
150,000
150,000 $9.56 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.